Search

Author/Creator Menter, Alexander

1. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 10 (October 2020)

Authors:
Kumar, Shaji K; Jacobus, Susanna J; Cohen, Adam D; Weiss, Matthias; Callander, Natalie; Singh, Avina K; Parker, Terri L; Menter, Alexander; Yang, Xuezhong; Parsons, Benjamin; Kumar, Pankaj; Kapoor, Prashant; Rosenberg, Aaron; Zonder, Jeffrey A; Faber, Edward; Lonial, Sagar; Anderson, Kenneth C; R...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 10(2020)
Page Start:
1317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗